These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18655368)

  • 101. Inhibition of N-cadherin and beta-catenin function reduces axon-induced Schwann cell proliferation.
    Gess B; Halfter H; Kleffner I; Monje P; Athauda G; Wood PM; Young P; Wanner IB
    J Neurosci Res; 2008 Mar; 86(4):797-812. PubMed ID: 17941050
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Preoperative serum E-cadherin assay in patients with ovarian carcinoma.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Ciampi B; Bianchi R; Genazzani AR
    Anticancer Res; 1999; 19(1B):769-72. PubMed ID: 10216491
    [TBL] [Abstract][Full Text] [Related]  

  • 103. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Prognostic significance of HLA-DR antigen in serous ovarian tumors.
    Tamiolakis D; Kotini A; Venizelos J; Jivannakis T; Simopoulos C; Papadopoulos N
    Clin Exp Med; 2003 Sep; 3(2):113-8. PubMed ID: 14598186
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].
    Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Alterations of M-cadherin, neural cell adhesion molecule and beta-catenin expression in satellite cells during overload-induced skeletal muscle hypertrophy.
    Ishido M; Uda M; Masuhara M; Kami K
    Acta Physiol (Oxf); 2006 Jul; 187(3):407-18. PubMed ID: 16776666
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer.
    Okada K; Shimura T; Asakawa K; Hashimoto S; Mochida Y; Suehiro T; Kuwano H
    Hepatogastroenterology; 2007; 54(73):17-21. PubMed ID: 17419223
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH; Uen YH; Tian YF; Sun CS; Sheu MJ; Kuo HT; Koay LB; Lin CY; Tzeng CC; Cheng CJ; Tang LY; Tsai SL; Wang AH
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1562-9. PubMed ID: 19423534
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Expression and clinical significance of Ki-67, E-cadherin, and mesothelin in serous borderline ovarian tumor.
    Yu N; Wang N; Liu YF; Li YY; Zhang TG
    Eur J Gynaecol Oncol; 2017; 38(1):85-90. PubMed ID: 29767871
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
    Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
    Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas.
    Imai T; Horiuchi A; Shiozawa T; Osada R; Kikuchi N; Ohira S; Oka K; Konishi I
    Hum Pathol; 2004 Dec; 35(12):1469-76. PubMed ID: 15619205
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
    Kim JH; Kim MA; Lee HS; Kim WH
    Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma].
    Gao Y; Zhao XL; Gu Q; Wang JY; Zhang SW; Zhang DF; Wang XH; Zhao N; Gao YT; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):585-9. PubMed ID: 20079185
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers.
    Bao LH; Sakaguchi H; Fujimoto J; Tamaya T
    J Biomed Sci; 2007 May; 14(3):373-81. PubMed ID: 17219251
    [TBL] [Abstract][Full Text] [Related]  

  • 115. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
    Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K
    Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer.
    Badiglian Filho L; Oshima CT; De Oliveira Lima F; De Oliveira Costa H; De Sousa Damião R; Gomes TS; Gonçalves WJ
    Oncol Rep; 2009 Feb; 21(2):313-20. PubMed ID: 19148501
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.
    Shim HS; Yoon BS; Cho NH
    Hum Pathol; 2009 May; 40(5):693-8. PubMed ID: 19157508
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.
    Wang H; Wang H; Makki MS; Wen J; Dai Y; Shi Q; Liu Q; Zhou X; Wang J
    Int J Clin Exp Pathol; 2014; 7(1):264-71. PubMed ID: 24427347
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
    Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.